Zanu-Brutanib and Zannab Root Nib

The first step is to talk to the patient whether a BTK inhibitor is their preferred first line. Zannab root nib has far fewer off target effects, particularly with atrial fibrillation,. But it's still indefinite therapy, and that's the discussion with the patient.